Concepedia

Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population

Cai‐Mei Zheng, Jia‐Yi Wang, Tzu-Ting Chen, Yun‐Chun Wu, Yi-Lien Wu, Hsin-Ting Lin, Sheng-Po Chiu, Tian-Jong Chang, Jing-Quan Zheng, Nain‐Feng Chu,

Scientific Reports · 2019 · 20 citations · 27 references

Open access

References

27

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25K citations

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.4K citations · Full text

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine · 1993 · 5.4K citations

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

The ONTARGET Investigators · New England Journal of Medicine · 2008 · 3.5K citations · Full text